PRLD — PRELUDE THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 81 SEC-registered investment managers reported holding PRLD (PRELUDE THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $226.18M across 42.46M shares. That is +3.1% by share count (+908.45K shares) versus the previous quarter, while reported value moved +60.7%. Ownership is concentrated: the five largest holders account for 66.2% of reported value and the top ten for 82.0%.
Compared with the prior quarter, 38 opened new positions, 25 added to existing stakes, 10 trimmed, 13 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of PRELUDE THERAPEUTICS INC (PRLD) include BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, ranked by reported 13F value among the 155 institutional holders on this page.
PRLD is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 60 | 11.42M | $44.64M | +13.4% |
| Q2 2026 | 81 | 42.46M | $226.18M | +3.1% |
| Q1 2026 | 56 | 30.40M | $103.96M | +9.1% |
| Q4 2025 | 50 | 28.74M | $81.16M | -4.1% |
| Q3 2025 | 48 | 28.66M | $40.00M | +4.4% |
| Q2 2025 | 53 | 27.95M | $21.86M | -4.6% |
| Q1 2025 | 60 | 31.27M | $26.75M | -2.1% |
| Q4 2024 | 61 | 33.26M | $41.12M | +7.4% |
Over the 8 quarters shown, institutional share counts decreased 66% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (+9.1%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.60M | $10.17M | 0.47% | New | |
| 1.90M | $7.42M | 0.00% | Reduce | |
| 1.86M | $7.26M | 0.00% | Add | |
| 717.36K | $2.81M | 0.00% | Reduce | |
| 662.92K | $2.59M | 0.00% | Add | |
| 556.53K | $2.18M | 0.00% | Add | |
| 520.10K | $2.03M | 0.00% | Add | |
| 297.71K | $1.16M | 0.00% | Add | |
| 266.67K | $1.04M | 0.00% | Add | |
| 235.76K | $921.81K | 0.00% | Reduce | |
| 192.54K | $752.82K | 0.00% | Reduce | |
| 150.92K | $590.10K | 0.00% | Add | |
| 142.82K | $558.42K | 0.00% | Reduce | |
| 140.88K | $550.85K | 0.00% | Add | |
| 137.54K | $537.00K | 0.00% | New | |
| 106.74K | $417.36K | 0.00% | New | |
| 89.04K | $348.53K | 0.00% | Add | |
| 68.19K | $266.61K | 0.00% | Hold | |
| 67.80K | $265.10K | 0.00% | Add | |
| 65.40K | $255.71K | 0.01% | Reduce | |
| 62.32K | $243.67K | 0.00% | Add | |
| 60.68K | $237.25K | 0.04% | New | |
| 59.98K | $234.51K | 0.00% | New | |
| 47.16K | $184.40K | 0.00% | Reduce | |
| 37.02K | $144.76K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.12M | $53.96M | 0.28% | Hold | |
| 6.48M | $34.52M | 0.30% | New | |
| 5.68M | $30.28M | 0.61% | Reduce | |
| 3.38M | $18.01M | 0.62% | New | |
| 2.42M | $12.87M | 0.71% | Add | |
| 2.01M | $10.71M | 0.00% | Add | |
| 1.80M | $9.58M | 0.00% | Add | |
| 1.02M | $5.44M | 0.76% | Add | |
| 993.37K | $5.29M | 0.01% | Add | |
| 900.90K | $4.80M | 0.27% | Add | |
| 844.99K | $4.50M | 0.00% | Add | |
| 844.99K | $4.50M | 0.01% | Add | |
| 841.86K | $4.49M | 0.00% | New | |
| 841.86K | $4.49M | 0.00% | Add | |
| 766.10K | $4.08M | 0.01% | New | |
| 503.86K | $2.69M | 0.00% | Add | |
| 318.80K | $1.70M | 0.00% | Add | |
| 284.89K | $1.52M | 0.00% | Add | |
| 281.20K | $1.50M | 0.00% | Add | |
| 240.60K | $1.28M | 0.00% | Add | |
| 193.92K | $1.03M | 0.00% | New | |
| 190.69K | $1.02M | 0.00% | Reduce | |
| 125.61K | $669.48K | 0.00% | Add | |
| 120.83K | $644.04K | 0.00% | Reduce | |
| 81.40K | $433.86K | 0.01% | New |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.91M | $37.31M | 0.77% | Hold | |
| 10.12M | $34.62M | 0.21% | Hold | |
| 1.59M | $5.45M | 0.35% | Add | |
| 1.23M | $4.21M | 0.00% | New | |
| 947.05K | $3.24M | 0.15% | New | |
| 923.63K | $3.16M | 0.01% | Add | |
| 558.34K | $1.91M | 0.32% | Add | |
| 382.74K | $1.31M | 0.00% | Add | |
| 382.74K | $1.31M | 0.00% | Add | |
| 358.91K | $1.23M | 0.00% | Add | |
| 322.16K | $1.10M | 0.00% | Reduce | |
| 321.89K | $1.10M | 0.00% | Add | |
| 302.46K | $1.03M | 0.00% | Add | |
| 275.20K | $941.18K | 0.00% | Add | |
| 236.47K | $808.72K | 0.00% | Add | |
| 192.96K | $659.93K | 0.00% | Add | |
| 157.38K | $538.24K | 0.00% | New | |
| 152.82K | $522.66K | 0.04% | New | |
| 138.23K | $472.75K | 0.00% | Add | |
| 124.38K | $425.37K | 0.00% | New | |
| 109.08K | $373.07K | 0.00% | Add | |
| 64.50K | $220.61K | 0.00% | Add | |
| 58.70K | $200.00K | 0.00% | New | |
| 57.19K | $195.59K | 0.00% | Add | |
| 56.52K | $193.32K | 0.00% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.91M | $31.64M | 0.67% | Hold | |
| 10.12M | $29.36M | 0.18% | Hold | |
| 1.41M | $4.10M | 0.00% | Add | |
| 788.87K | $2.29M | 0.15% | New | |
| 788.70K | $2.29M | 0.01% | Add | |
| 755.96K | $2.19M | 0.00% | Reduce | |
| 334.92K | $971.26K | 0.00% | Add | |
| 273.88K | $794.26K | 0.00% | New | |
| 272.89K | $791.50K | 0.00% | Add | |
| 271.30K | $786.77K | 0.00% | Reduce | |
| 266.28K | $772.21K | 0.00% | Hold | |
| 237.30K | $688.17K | 0.00% | Add | |
| 160.65K | $465.89K | 0.00% | Hold | |
| 151.00K | $437.89K | 0.00% | Reduce | |
| 151.00K | $437.89K | 0.00% | Reduce | |
| 127.29K | $369.15K | 0.00% | Add | |
| 122.75K | $355.98K | 0.07% | New | |
| 117.48K | $340.68K | 0.00% | Add | |
| 111.04K | $322.02K | 0.00% | Add | |
| 73.00K | $211.70K | 0.00% | New | |
| 70.55K | $200.43K | 0.00% | Add | |
| 59.17K | $171.59K | 0.00% | New | |
| 53.50K | $155.15K | 0.00% | Hold | |
| 50.16K | $145.46K | 0.00% | Add | |
| 50.12K | $145.35K | 0.00% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.91M | $15.71M | 0.40% | Hold | |
| 10.12M | $14.58M | 0.11% | Hold | |
| 1.15M | $1.65M | 0.00% | Add | |
| 1.15M | $1.65M | 0.00% | Add | |
| 992.85K | $1.43M | 0.00% | Add | |
| 876.34K | $1.26M | 0.00% | Reduce | |
| 544.00K | $783.36K | 0.00% | Reduce | |
| 284.20K | $409.25K | 0.00% | Hold | |
| 264.97K | $381.56K | 0.00% | Reduce | |
| 222.70K | $320.69K | 0.00% | Reduce | |
| 217.57K | $313.37K | 0.00% | Hold | |
| 160.65K | $231.34K | 0.00% | Hold | |
| 152.23K | $219.22K | 0.00% | Reduce | |
| 100.00K | $144.00K | 0.03% | Add | |
| 97.59K | $140.53K | 0.00% | Hold | |
| 79.33K | $114.23K | 0.00% | Reduce | |
| 75.16K | $108.00K | 0.01% | Add | |
| 69.25K | $99.72K | 0.00% | Hold | |
| 53.50K | $77.04K | 0.00% | Reduce | |
| 36.42K | $52.45K | 0.00% | Reduce | |
| 34.82K | $50.14K | 0.00% | Reduce | |
| 34.33K | $49.44K | 0.00% | Reduce | |
| 25.84K | $37.21K | 0.00% | New | |
| 16.90K | $24.00K | 0.00% | New | |
| 15.58K | $22.43K | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.91M | $8.83M | 0.23% | Hold | |
| 10.12M | $8.19M | 0.08% | Hold | |
| 932.57K | $754.45K | 0.00% | Reduce | |
| 927.61K | $743.00K | 0.00% | Reduce | |
| 581.80K | $470.91K | 0.00% | Reduce | |
| 432.56K | $350.11K | 0.00% | Reduce | |
| 284.38K | $230.18K | 0.00% | Reduce | |
| 248.42K | $201.07K | 0.00% | Add | |
| 248.42K | $201.07K | 0.00% | Add | |
| 225.00K | $182.12K | 0.00% | Reduce | |
| 217.57K | $176.13K | 0.00% | Reduce | |
| 211.86K | $171.48K | 0.01% | New | |
| 160.65K | $130.03K | 0.00% | Hold | |
| 154.98K | $125.44K | 0.00% | Reduce | |
| 149.18K | $120.75K | 0.00% | Reduce | |
| 104.20K | $84.30K | 0.00% | Add | |
| 97.59K | $78.99K | 0.00% | Reduce | |
| 91.75K | $74.27K | 0.00% | New | |
| 88.50K | $71.63K | 0.00% | Hold | |
| 80.84K | $65.44K | 0.00% | Reduce | |
| 80.84K | $65.44K | 0.00% | Reduce | |
| 75.00K | $60.70K | 0.01% | New | |
| 71.38K | $58.00K | 0.00% | New | |
| 69.25K | $56.05K | 0.00% | Hold | |
| 47.79K | $38.68K | 0.00% | New |
New Positions (Q2 2026)
- RA CAPITAL MANAGEMENT, L.P. 6.48M sh · $34.52M
- Soleus Capital Management, L.P. 3.38M sh · $18.01M
- GEODE CAPITAL MANAGEMENT, LLC 841.86K sh · $4.49M
- ADAGE CAPITAL PARTNERS GP, L.L.C. 766.10K sh · $4.08M
- VANGUARD PORTFOLIO MANAGEMENT LLC 193.92K sh · $1.03M
- Hillsdale Investment Management Inc. 81.40K sh · $433.86K
- BNY Mellon 68.19K sh · $363.44K
- Charles Schwab Investment Management 67.62K sh · $360.43K
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 67.62K sh · $360.43K
- Sixth Street Partners Management Company, L.P. 67.62K sh · $360.43K
- Squarepoint Ops LLC 59.54K sh · $317.35K
- PANAGORA ASSET MANAGEMENT INC 47.57K sh · $253.57K
Fully Exited (vs previous quarter)
- EcoR1 Capital, LLC sold 947.05K sh · $3.24M
- STATE STREET CORP sold 138.23K sh · $472.75K
- HRT FINANCIAL LP sold 58.70K sh · $200.00K
- XTX Topco Ltd sold 57.19K sh · $195.59K
- Focus Partners Wealth sold 50.01K sh · $171.02K
- OMERS ADMINISTRATION Corp sold 32.70K sh · $111.83K
- Prudential Financial sold 17.42K sh · $59.58K
- Point72 Asset Management sold 16.33K sh · $55.84K
- Diametric Capital, LP sold 11.98K sh · $40.97K
- NINE MASTS CAPITAL Ltd sold 11.70K sh · $40.01K
- AMERICAN CENTURY COMPANIES INC sold 10.29K sh · $35.20K
- CALDWELL SUTTER CAPITAL, INC. sold 1.00K sh · $3.42K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 2.60M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.90M | 2.01M | 1.23M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 1.86M | 1.80M | 321.89K | 266.28K | 264.97K | 432.56K | 1.05M | 1.07M | 1.06M | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 717.36K | 841.86K | 302.46K | 272.89K | 217.57K | 217.57K | 404.95K | 402.34K | 391.72K | 361.95K | 361.63K | 349.37K | 331.10K | 242.29K | 145.90K | 144.68K | 153.09K | 135.64K | 207.58K | 212.64K |
| STATE STREET CORP | 662.92K | — | 138.23K | 127.29K | 97.59K | 97.59K | 286.05K | 293.40K | 286.05K | 211.75K | 211.44K | 212.23K | 187.21K | — | — | — | — | — | — | — |
| UBS Group AG | 556.53K | 318.80K | 64.50K | 1.86K | 4.17K | 104.20K | 96.16K | 67.39K | 7.02K | 10.93K | 15.65K | 19.87K | 7.41K | 6.89K | 980 | 1.04K | 68 | 2.71K | 183 | 1.94K |
| Morgan Stanley | 520.10K | 503.86K | 322.16K | 334.92K | 284.20K | 284.38K | 302.78K | 365.16K | 323.69K | 287.35K | 296.20K | 298.80K | 244.47K | 195.33K | 141.66K | 89.95K | 177.79K | 480.79K | 546.48K | 845.71K |
| Renaissance Technologies | 297.71K | 281.20K | 275.20K | 271.30K | 544.00K | 581.80K | 656.70K | 634.50K | 196.90K | 206.60K | 244.80K | 216.40K | 139.37K | 183.30K | 138.50K | 136.50K | 143.40K | 160.49K | 40.10K | 127.20K |
| Connor, Clark & Lunn Investment Management Ltd. | 266.67K | 125.61K | 109.08K | 46.09K | — | — | — | — | 17.29K | 12.35K | 20.07K | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 235.76K | 284.89K | 157.38K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 192.54K | 193.92K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 150.92K | 13.11K | 16.42K | 21.55K | — | — | — | — | — | 3.13K | — | — | — | — | — | — | — | — | — | — |
| Marshall Wace | 142.82K | 190.69K | 358.91K | 273.88K | — | 41.75K | — | 392.15K | 359.14K | — | — | — | — | — | — | — | — | 45.72K | 111.78K | 268.02K |
| Squarepoint Ops LLC | 140.88K | 59.54K | — | — | — | — | — | — | — | — | — | 29.42K | 88.80K | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 137.54K | — | 58.70K | — | 16.90K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Arrowstreet Capital | 106.74K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 89.04K | 35.21K | 35.21K | — | — | — | — | 10.98K | 29.08K | 29.07K | 14.30K | 14.30K | 11.19K | — | — | — | — | — | — | — |
| BNY Mellon | 68.19K | 68.19K | — | — | — | — | 28.61K | 28.61K | 28.61K | 36.28K | 40.07K | 50.60K | 32.88K | 30.82K | — | 28.88K | 29.18K | 29.19K | 59.82K | 57.68K |
| JANE STREET GROUP, LLC | 67.80K | 20.10K | 192.96K | 111.04K | 34.82K | 91.75K | — | — | 10.36K | 12.95K | 16.39K | 32.98K | — | — | — | — | — | — | — | — |
| Hillsdale Investment Management Inc. | 65.40K | 81.40K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold PRLD?
As of 2026-Q2, 81 institutional funds reported holding PRLD (PRELUDE THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $226.18M.
How many shares of PRLD do institutions own?
13F filers reported 42.46M shares of PRLD, worth $226.18M in aggregate at the end of 2026-Q2.
Is institutional ownership of PRLD rising or falling?
Share counts moved +3.1% versus the prior quarter — accumulation.
Who are the top institutional holders of PRLD?
The largest 13F holders are BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, Soleus Capital Management, L.P., Kynam Capital Management, LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of PRELUDE THERAPEUTICS INC?
The major shareholders of PRELUDE THERAPEUTICS INC (PRLD) by reported 13F value are BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, Soleus Capital Management, L.P., Kynam Capital Management, LP, among 155 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.